By processing Pearson correlation analysis to calculate the expression of HTR5A and PRKAA1 in different WHO grading gliomas, we found that the expression levels of HTR5A had a linear correlation with the PRKAA1 in glioma specimens, r=0.48, P <0.05 (Fig. 1H). This evidence concerns the gene HTR5A and central nervous system cancer.